Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor expression for the estrogen receptor-bad breast cancer

Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor expression for the estrogen receptor-bad breast cancer

Bieche I, Parfait B, Tozlu S, Lidereau R, Vidaud Yards: Quantitation out-of androgen receptor gene term for the sporadic breast tumors from the real-big date RT-PCR: evidence one MYC was an AR-managed gene. Carcinogenesis. 2001, 22 (9): 1521-1526. /carcin/twenty two.nine.1521.

Bratthauer GL, Lininger RA, Son YG, Tavassoli FA: Androgen and you may the hormone estrogen receptor mRNA updates in the apocrine carcinomas. Diagn Mol Pathol. 2002, eleven (2): 113-118. 9606-200206000-00008.

Gatalica Z: Immunohistochemical data out-of apocrine breast lesions. Uniform more-phrase of androgen receptor accompanied by the loss of the hormone estrogen and you can progesterone receptors in the apocrine metaplasia and you can apocrine carcinoma within the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.

Am J Clin Pathol

Soreide JA, Lea OA, Varhaug JE, Skarstein An excellent, Kvinnsland S: Androgen receptors into the operable cancer of the breast: regards to other steroid hormone receptors, correlations so you’re able to prognostic factors and you may predictive worthy of for effectation of additive tamoxifen cures. Eur J Surg Oncol. 1992, 18 (2): 112-118.

Bayer-Gather IB, Smoller B: Androgen receptors: an excellent marker to improve awareness getting pinpointing cancer of the breast in facial skin metastasis off unknown pri, thirteen (2): 119-122. /modpathol.3880021.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and health-related effects. J Clin Oncol. 2000, 18 (5): 1135-1149.

Pang ST, Flores-Morales Good, Skoog L, Chuan YC, Nordstedt G, Pousette An excellent: Control from matrix metalloproteinase 13 phrase by the androgen inside prostate cancer tumors. Oncol Rep. 2004, eleven (6): 1187-1192.

Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.

Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Assessment of the prognostic requirement for androgen receptor expression during the metastatic cancer of the breast. Virchows Arch. 2006, 449 (1): 24-31. /s00428-006-0213-6.

Parker RL, Hunter DG, Lesack DW, Cupples JB, Grant DR, Akbari Yards, Gilks CB: Comparison out-of interlaboratory version about immunohistochemical devotion out of estrogen receptor status playing with a cancer of the breast tissues microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.

Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Study of matrix metalloproteinases in addition to their inhibitors during the breast cancer. Br J Cancers. 2007, 96 (6): 903-911. /sj.bjc.6603666.

Narita D, Raica M, Suciu C, Cimpean A good, Anghel A beneficial: Immunohistochemical term of androgen receptor and you may prostate-specific antigen inside breast cancer. Folia Histochem Cytobiol. 2006, forty two (3): 165-172.

Egeblad Meters, Werb Z: The latest qualities on the matrix metalloproteinases within the cancer advancement. Nat Rev Malignant tumors. 2002, dos (3): 161-174. /nrc745.

Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–into the fundamental phase out of cancer?. Disease Phone. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.

Manes S, Llorente Meters, Lacalle RA, Gomez-Mouton C, Kremer L, Mira Elizabeth, Martinez Air-con: New matrix metalloproteinase-nine controls the fresh insulin-instance growth basis-caused autocrine effect inside the DU-145 carcinoma cells. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..

Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel Age, Matrisian LM, Mareel Yards: Launch of an intrusion promoter Age-cadherin fragment by the matrilysin and you can stromelysin-1. J Cellphone Sci. 2001, 114 (Pt 1): 111-118.

Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] phrase picks to own cells with just minimal susceptibility so you’re able to apoptosis. Neoplasia. 2001, 3 (6): 459-468. /sj.neo.7900190.


Stetler-Stevenson WG: Matrix metalloproteinases inside the angiogenesis: a relocation target having healing intervention. J Clin Invest. 1999, 103 (9): 1237-1241. /JCI6870.

Cornelius La, Nehring LC, Harding E, Bolanowski Meters, Welgus HG, Kobayashi DK, Penetrate RA, Shapiro SD: Matrix metalloproteinases build angiostatin: effects on the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.

Jiang Y, Goldberg ID, Shi YE: Cutting-edge opportunities out of tissues inhibitors away from metalloproteinases inside the cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.

Deja un comentario